Literature DB >> 2648537

Epidemiology of toxic shock syndrome in the United States: overview.

C V Broome1.   

Abstract

Studies were undertaken to detect a possible reporting or diagnostic bias that might have affected the results of previous epidemiologic investigations of toxic shock syndrome (TSS). The methods used in this reassessment of initial findings regarding TSS epidemiology (which were obtained through passive- and active-surveillance systems) included record review and analysis of discharge diagnoses. Results obtained with both the latter methods confirmed the broad outlines of the descriptive epidemiology of TSS. Some recent studies have focused on nonmenstrual cases of TSS and on risk factors for the development of TSS. Key findings include the more frequent isolation from nonmenstrual TSS cases of Staphylococcus aureus strains not producing TSS toxin 1 and a higher case-fatality rate for cases in men and for "non-vaginal" cases in women than for vaginal cases (defined as menstrual, postpartum, vaginal nonmenstrual, and contraceptive cases). Studies of the relation between tampon use and TSS suggest that both the degree of absorbency and the chemical composition of the tampon are involved; however, the mechanism by which tampons increase the risk of TSS remains unknown. Contraceptive sponges and diaphragms may be linked to an increased risk of nonmenstrual TSS, whereas oral contraceptives may play a protective role; these possibilities require further study.

Entities:  

Mesh:

Year:  1989        PMID: 2648537     DOI: 10.1093/clinids/11.supplement_1.s14

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  5 in total

1.  Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.

Authors:  Jeffrey Parsonnet; Melanie A Hansmann; Mary L Delaney; Paul A Modern; Andrea M Dubois; Wendy Wieland-Alter; Kimberly W Wissemann; John E Wild; Michaelle B Jones; Jon L Seymour; Andrew B Onderdonk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Toxic shock syndrome in the United States: surveillance update, 1979 1996.

Authors:  R A Hajjeh; A Reingold; A Weil; K Shutt; A Schuchat; B A Perkins
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

3.  One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases.

Authors:  E Descloux; T Perpoint; T Ferry; G Lina; M Bes; F Vandenesch; I Mohammedi; J Etienne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01       Impact factor: 3.267

4.  The Association Between Onset of Staphylococcal Non-menstrual Toxic Shock Syndrome With Inducibility of Toxic Shock Syndrome Toxin-1 Production.

Authors:  Yusuke Taki; Shinya Watanabe; Yusuke Sato'o; Xin-Ee Tan; Hisaya K Ono; Kotaro Kiga; Yoshifumi Aiba; Teppei Sasahara; Aa Haeruman Azam; Kanate Thitiananpakorn; Srivani Veeranarayanan; Feng-Yu Li; Yuancheng Zhang; Tomofumi Kawaguchi; Sarah Hossain; Dong-Liang Hu; Longzhu Cui
Journal:  Front Microbiol       Date:  2022-03-14       Impact factor: 5.640

5.  Toxic shock syndrome responsive to steroids.

Authors:  Nikhil Vergis; David A Gorard
Journal:  J Med Case Rep       Date:  2007-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.